{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:42:17Z","timestamp":1793364137545,"version":"4.5.0"},"reference-count":21,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,8,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>To specify the incidence and risk factors for secondary autoimmune diseases (ADs) after HSCT for a primary AD, we retrospectively analyzed AD patients treated by HSCT reported to EBMT from 1995 to 2009 with at least 1 secondary AD (cases) and those without (controls). After autologous HSCT, 29 of 347 patients developed at least 1 secondary AD within 21.9 (0.6-49) months and after allogeneic HSCT, 3 of 16 patients. The observed secondary ADs included: autoimmune hemolytic anemia (n = 3), acquired hemophilia (n = 3), autoimmune thrombocytopenia (n = 3), antiphospholipid syndrome (n = 2), thyroiditis (n = 12), blocking thyroid-stimulating hormone receptor antibody (n = 1), Graves disease (n = 2), myasthenia gravis (n = 1), rheumatoid arthritis (n = 2), sarcoidosis (n = 2), vasculitis (n = 1), psoriasis (n = 1), and psoriatic arthritis (n = 1). After autologous HSCT for primary AD, the cumulative incidence of secondary AD was 9.8% \u00b1 2% at 5 years. Lupus erythematosus as primary AD, and antithymocyte globulin use plus CD34+ graft selection were important risk factors for secondary AD by multivariate analysis. With a median follow-up of 6.2 (0.54-11) years after autologous HSCT, 26 of 29 patients with secondary AD were alive, 2 died during their secondary AD (antiphospholipid syndrome, hemophilia), and 1 death was HSCT-related. This European multicenter study underlines the need for careful management and follow-up for secondary AD after HSCT.<\/jats:p>","DOI":"10.1182\/blood-2011-02-336156","type":"journal-article","created":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T01:19:37Z","timestamp":1305854377000},"page":"1693-1698","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":162,"title":["Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party"],"prefix":"10.1182","volume":"118","author":[{"given":"Thomas","family":"Daikeler","sequence":"first","affiliation":[{"name":"Department of Rheumatology, University Hospital Basel, Basel, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Labopin","sequence":"additional","affiliation":[{"name":"H\u00f4pital Saint Antoine, service d'h\u00e9matologie et th\u00e9rapie cellulaire, Assistance Publique des Hopitaux de Paris (AP-HP), European Blood and Marrow Transplantation office, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Di Gioia","sequence":"additional","affiliation":[{"name":"Haematology Department, Careggi University Hospital, Florence, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Abinun","sequence":"additional","affiliation":[{"name":"Newcastle General Hospital, Newcastle upon Tyne, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Alexander","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Charit\u00e9, Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Miniati","sequence":"additional","affiliation":[{"name":"Department of Biomedicine, Division of Rheumatology, University of Florence, Florence, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Gualandi","sequence":"additional","affiliation":[{"name":"Department of Haematology II, Ospedale San Martino, Genova, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Fassas","sequence":"additional","affiliation":[{"name":"Neurology and Haematology, George Papanicolau Hospital, Thessaloniki, Greece;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Martin","sequence":"additional","affiliation":[{"name":"Service d'Immunologie Clinique, Universit\u00e9 de Strasbourg, Strasbourg, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl Philipp","family":"Schwarze","sequence":"additional","affiliation":[{"name":"Paediatric Haematology and Endocrinology, University Children's Hospital T\u00fcbingen, T\u00fcbingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Wulffraat","sequence":"additional","affiliation":[{"name":"University Medical Center Utrecht, Utrecht, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Buch","sequence":"additional","affiliation":[{"name":"Section of Musculoskeletal Disease, University of Leeds, Chapel Allerton Hospital, Leeds, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Sampol","sequence":"additional","affiliation":[{"name":"Hospital Universitari Son Espases, Palma De Mallorca, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enric","family":"Carreras","sequence":"additional","affiliation":[{"name":"Department of Hematology, Institute of Hematology & Oncology, Hospital Clinic, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicte","family":"Dubois","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospitals Leuven, Leuven, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Gruhn","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Jena, Jena, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayfun","family":"G\u00fcng\u00f6r","sequence":"additional","affiliation":[{"name":"Division of Immunology\/Hematology\/BMT, University Children's Hospital, Z\u00fcrich, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pohlreich","sequence":"additional","affiliation":[{"name":"Charles University Hospital, Prague, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemie","family":"Schuerwegh","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilian","family":"Snarski","sequence":"additional","affiliation":[{"name":"Department of Hematology & Oncology, Central Clinical Hospital, Medical University of Warsaw, Warsaw, Poland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Snowden","sequence":"additional","affiliation":[{"name":"Department of Haematology, Sheffield Teaching Hospitals National Health Service (NHS) Foundation Trust, and Department of Oncology, University of Sheffield, Sheffield, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Veys","sequence":"additional","affiliation":[{"name":"Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Fasth","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Gothenburg, Gothenburg, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stig","family":"Lenhoff","sequence":"additional","affiliation":[{"name":"Department of Hematology, University Hospital, Lund, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Messina","sequence":"additional","affiliation":[{"name":"Dipartimento di Pediatria, Clinica di Oncoematologia Pediatrica, Padova, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Voswinkel","sequence":"additional","affiliation":[{"name":"Department of Hematology, H\u00f4pital Saint Antoine, AP-HP, and Universit\u00e9 Pierre et Marie Curie, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Badoglio","sequence":"additional","affiliation":[{"name":"European Blood and Marrow Transplantation Study Office, Facult\u00e9 de M\u00e9decine Saint-Antoine, Unite Mixte de Recherche S938, CEREST-TC European Blood and Marrow Transplantation, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Henes","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology University Hospital T\u00fcbingen, T\u00fcbingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Launay","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hopital Claude Huriez, Lille, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Tyndall","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University Hospital Basel, Basel, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliane","family":"Gluckman","sequence":"additional","affiliation":[{"name":"Clinical Research Unit, Eurocord office, H\u00f4pital Saint Louis AP-HP, Paris, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Farge","sequence":"additional","affiliation":[{"name":"Internal Medicine and Vascular Pathology Unit, Inserm U976, Saint Louis Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the EBMT Autoimmune Disease Working Party","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2019111808050106600_B1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.beha.2006.09.008","article-title":"Autoimmunity following haematopoietic stem-cell transplantation.","volume":"20","author":"Daikeler","year":"2007","journal-title":"Best Pract Res Clin Haematol"},{"issue":"2","key":"2019111808050106600_B2","first-page":"123","article-title":"Thyroid function after autologous bone marrow transplantation.","volume":"10","author":"Carlson","year":"1992","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"2019111808050106600_B3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/sj.bmt.1705641","article-title":"Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients.","volume":"39","author":"Sanz","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"2019111808050106600_B4","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/sj.bmt.1700759","article-title":"Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literature.","volume":"19","author":"Mackey","year":"1997","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2019111808050106600_B5","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3324\/haematol.2009.013458","article-title":"Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases.","volume":"95","author":"Farge","year":"2010","journal-title":"Haematologica"},{"issue":"9191","key":"2019111808050106600_B6","first-page":"1691","article-title":"Are individuals with an autoimmune disease at higher risk of a second autoimmune disorder?","volume":"354","author":"Somers","year":"2009","journal-title":"Am J Epidemiol"},{"issue":"6","key":"2019111808050106600_B7","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1182\/blood-2006-07-035766","article-title":"Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: role of conditioning regimen used.","volume":"109","author":"Loh","year":"2007","journal-title":"Blood"},{"issue":"26","key":"2019111808050106600_B8","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1056\/NEJMc076383","article-title":", Multiple autoimmune diseases after autologous stem-cell transplantation.","volume":"357","author":"Bohgaki","year":"2007","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111808050106600_B9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.humimm.2010.01.013","article-title":"New onset of myasthenia gravis after treatment of systemic sclerosis by autologous hematopoietic stem cell transplantation: sustained autoimmunity or inadequate reset of tolerance?","volume":"71","author":"Deligny","year":"2010","journal-title":"Hum Immunol"},{"key":"2019111808050106600_B10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med"},{"key":"2019111808050106600_B11","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for subdistribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Statist Assoc"},{"issue":"5","key":"2019111808050106600_B12","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/art.21036","article-title":"Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis.","volume":"52","author":"Farge","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"4","key":"2019111808050106600_B13","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/ard.2004.029009","article-title":"Fever and increasing cANCA titre after kidney and autologous stem cell transplantation for Wegener's granulomatosis.","volume":"64","author":"Daikeler","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2019111808050106600_B14","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3109\/08916930903374600","article-title":"Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future.","volume":"43","author":"Jacob","year":"2010","journal-title":"Autoimmunity"},{"issue":"11","key":"2019111808050106600_B15","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1084\/jem.20040168","article-title":"Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB\/W mice.","volume":"199","author":"Hoyer","year":"2004","journal-title":"J Exp Med"},{"issue":"11","key":"2019111808050106600_B16","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s10067-010-1510-7","article-title":"The imbalance between regulatory and IL-17-secreting CD4+ T cells in lupus patients.","volume":"29","author":"Ma","year":"2010","journal-title":"Clin Rheumatol"},{"issue":"2","key":"2019111808050106600_B17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0092-8674(04)00335-6","article-title":"Homeostatic expansion of T cells during immune insufficiency generates autoimmunity.","volume":"117","author":"King","year":"2004","journal-title":"Cell"},{"issue":"8","key":"2019111808050106600_B18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/08916930802197081","article-title":"Immune re-education following autologous hematopoietic stem cell transplantation.","volume":"41","author":"Abrahamsson","year":"2008","journal-title":"Autoimmunity"},{"issue":"1","key":"2019111808050106600_B19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cell.2007.06.033","article-title":"Multistep pathogenesis of autoimmune disease.","volume":"130","author":"Goodnow","year":"2007","journal-title":"Cell"},{"key":"2019111808050106600_B20","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.bbmt.2008.07.006","article-title":"Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation.","volume":"14","author":"Page","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"2019111808050106600_B21","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.autrev.2007.11.005","article-title":"Autoimmune disease after autologous hematopoietic stem cell transplantation.","volume":"7","author":"Bohgaki","year":"2008","journal-title":"Autoimmun Rev"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/6\/1693\/1347156\/zh803211001693.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/6\/1693\/1347156\/zh803211001693.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T08:21:47Z","timestamp":1574065307000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/118\/6\/1693\/29161\/Secondary-autoimmune-diseases-occurring-after-HSCT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,11]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,8,11]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-02-336156","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,11]]}}}